Accelmed Partners II L.P.
CIK 1807256 · last filed 2022-11-23
Accelmed Partners II L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider bought $585.0K of NPCE on Nov 23, 2022. Across all open-market trades the lifetime net is +$10.6M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $66.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$66.87M
1
3
$10.59M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NPCE | 10%+ Owner | 4,370,550 | $15.30 | $66.87M | $10.59M | 3 | 2022-11-23 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-23 | NPCE | Buy (P) | +390,291 | $585.0K | EDGAR |
| 2021-04-26 | NPCE | Conv (C) | +3,454,422 | $0 | EDGAR |
| 2021-04-23 | NPCE | Buy (P) | +588,235 | $10.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.